Tigecycline-related pancreatitis: A review of spontaneous adverse event reports

Pharmacotherapy

Volumn 33, Issue 1, 2013, Pages 63-68

  Okon, Emmanuel ^a   Engell, Christian ^a   Van Manen, Robbert ^b   Brown, Jack ^c,d  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^b Health Sciences   (Netherlands)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Adverse drug reaction; Antimicrobials; Pancreatitis; Tetracycline; Tigecycline

Indexed keywords

AMLODIPINE; ANTIBIOTIC AGENT; ATROPINE; BUSPIRONE; CALCIUM; CARVEDILOL; CITALOPRAM; CYCLOBENZAPRINE; DOXAZOSIN; DOXYCYCLINE; ENOXAPARIN; GENTAMICIN; GUAIFENESIN; HYDRALAZINE; INSULIN; LABETALOL; LEVOFLOXACIN; METHYLPREDNISOLONE; METRONIDAZOLE; MINOCYCLINE; ONDANSETRON; OSELTAMIVIR; RECOMBINANT ERYTHROPOIETIN; RIFAMPICIN; TEMAZEPAM; TETRACYCLINE; TIGECYCLINE; TRAZODONE; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ATYPICAL MYCOBACTERIOSIS; CATHETER INFECTION; CELLULITIS; CHILD; COHORT ANALYSIS; COLITIS; CONTROLLED STUDY; DECUBITUS; DIVERTICULITIS; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI INFECTION; FEMALE; FEVER; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HUMAN; INFECTION; INFLUENZA; LUNG INFECTION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEOMYELITIS; PANCREATITIS; PELVIS ABSCESS; PERITONITIS; PNEUMONIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SEPSIS; SEX DIFFERENCE; STAPHYLOCOCCUS INFECTION; URINARY TRACT INFECTION; WOUND INFECTION;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; PANCREATITIS; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84875448769     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1159     Document Type: Review

References (17)

1. Seputiene V, Povilonis J, Armalyte J, Suziedelis K, Pavilonis A, Suziedeliene E. Tigecycline-how powerful is it in the fight against antibiotic-resistant bacteria? Medicina (Kaunas) 2010;46(4):240-8.
2. Noskin GA. Tigecycline: a new glycylcycline for treatment of serious infections. Clin Infect Dis 2005;41(suppl 5):S303-14.
3. Wyeth Pharmaceuticals, Inc. Tygacil (tigecycline) prescribing information. Collegeville, PA; 2010.
4. Hung WY, Kogelman L, Volpe G, et al. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents 2009;34:486-9.
5. Port-Labarthe S, Youdaren R, Benkerrou M, Basmaci R, Lorrot M. Pediatric acute pancreatitis related to tigecycline. Pediatr Infect Dis J 2010;29:890-1.
6. Gilson M, Moachon L, Jeanne L, et al. Acute pancreatitis related to tigecycline: case report and review of the literature. Scand J Infect Dis 2008;40:681-3.
7. Lipshitz J, Kruh J, Cheung P, Cassagnol M. Tigecyclineinduced pancreatitis. J Clin Gastroenterol 2009;43:93.
8. Marshall SR. Tigecycline-induced pancreatitis. Hosp Pharm 2009;44:239-41.
9. Mascarello M, Papa G, Arnez ZM, Luzzati R. Acute necrotizing pancreatitis related to tigecycline. J Antimicrob Chemother 2012;67:1296-7.
10. van Manen RP, Du Mouchel W. Signal detection methodologies to support effective safety management. Expert Opin Drug Saf 2007;6:451-64.
11. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher than expected combinations of drugs and events in the US. FDA's spontaneous reports database. Drug Saf 2002;25:381-92.
12. Elmore MF, Rogge JD. Tetracycline-induced pancreatitis. Gastroneterology 1981;81:1134-6.
13. Steinberg WM. Acute drug and toxin induced pancreatitis. Hosp Pract 1985;20:95-102.
14. U.S. Food and Drug Administration. FDA drug safety communication: increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections (Sept 2010). Available from http://www.fda.gov/DrugsSafety/ucm224370.htm. Accessed November 14, 2011.
15. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007;5(6):648-61; quiz 644.
16. Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 2004;13:519-23.
17. Waller P, Van Puijenbroek E, Evans S. The reporting odds ratio versus the proportional reporting ratio: 'deuce.' Pharmacoepidemiol Drug Saf 2004;13:525-8.